Robert James Mchale, MD | |
350 Pee Dee Ave, Suite A, Albemarle, NC 28001-4932 | |
(704) 986-1500 | |
Not Available |
Full Name | Robert James Mchale |
---|---|
Gender | Male |
Speciality | Psychiatry |
Experience | 19 Years |
Location | 350 Pee Dee Ave, Albemarle, North Carolina |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1841412053 | NPI | - | NPPES |
Facility Name | Location | Facility Type |
---|---|---|
Stanly Regional Medical Center | Albemarle, NC | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Monarch | 0244273852 | 64 |
News Archive
ImmunoCellular Therapeutics, Ltd. announced that updated efficacy and safety data from the phase II trial of dendritic cell-based immunotherapeutic vaccine ICT-107 in patients with newly diagnosed glioblastoma multiforme (GBM) were presented at the 2014 American Society for Clinical Oncology (ASCO) annual meeting in Chicago.
Antidepressants are safe, with adverse effects generally being due to existing psychiatric conditions, according to new research.
An exploration of the beauty and wonder of the hormones that control our energy balance and metabolism and how they can be replaced and manipulated to improve human health will be the focus of a lecture celebrating the centenary of insulin by Professor Sir Stephen O'Rahilly at the Royal Society of Medicine on Thursday 2 December 2021.
The Drugs for Neglected Diseases initiative welcomes the announcement by UNITAID to grant up to USD 17.3 million to the organization for its paediatric HIV programme.
› Verified 6 days ago
Entity Name | Monarch |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1801116405 PECOS PAC ID: 0244273852 Enrollment ID: O20050728000103 |
News Archive
ImmunoCellular Therapeutics, Ltd. announced that updated efficacy and safety data from the phase II trial of dendritic cell-based immunotherapeutic vaccine ICT-107 in patients with newly diagnosed glioblastoma multiforme (GBM) were presented at the 2014 American Society for Clinical Oncology (ASCO) annual meeting in Chicago.
Antidepressants are safe, with adverse effects generally being due to existing psychiatric conditions, according to new research.
An exploration of the beauty and wonder of the hormones that control our energy balance and metabolism and how they can be replaced and manipulated to improve human health will be the focus of a lecture celebrating the centenary of insulin by Professor Sir Stephen O'Rahilly at the Royal Society of Medicine on Thursday 2 December 2021.
The Drugs for Neglected Diseases initiative welcomes the announcement by UNITAID to grant up to USD 17.3 million to the organization for its paediatric HIV programme.
› Verified 6 days ago
Mailing Address | Practice Location Address |
---|---|
Robert James Mchale, MD 350 Pee Dee Ave, Suite A, Albemarle, NC 28001-4932 Ph: (704) 986-1500 | Robert James Mchale, MD 350 Pee Dee Ave, Suite A, Albemarle, NC 28001-4932 Ph: (704) 986-1500 |
News Archive
ImmunoCellular Therapeutics, Ltd. announced that updated efficacy and safety data from the phase II trial of dendritic cell-based immunotherapeutic vaccine ICT-107 in patients with newly diagnosed glioblastoma multiforme (GBM) were presented at the 2014 American Society for Clinical Oncology (ASCO) annual meeting in Chicago.
Antidepressants are safe, with adverse effects generally being due to existing psychiatric conditions, according to new research.
An exploration of the beauty and wonder of the hormones that control our energy balance and metabolism and how they can be replaced and manipulated to improve human health will be the focus of a lecture celebrating the centenary of insulin by Professor Sir Stephen O'Rahilly at the Royal Society of Medicine on Thursday 2 December 2021.
The Drugs for Neglected Diseases initiative welcomes the announcement by UNITAID to grant up to USD 17.3 million to the organization for its paediatric HIV programme.
› Verified 6 days ago
Douglas Smith, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 350 Pee Dee Ave, Suite A, Albemarle, NC 28001 Phone: 704-983-8868 | |
Olav Nilender, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 301 Yadkin St, Albemarle, NC 28001 Phone: 704-984-4480 | |
Dr. Dianne Frances Mcqueen, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 1000 N 1st St, Suite 1, Albemarle, NC 28001 Phone: 704-983-2117 Fax: 704-983-2636 | |
Dr. Mariel Melissa Litz, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 350 Pee Dee Ave, Suite A, Albemarle, NC 28001 Phone: 704-986-1500 Fax: 336-641-3089 | |
Dr. David William Schmidt, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 923 N 2nd St, Ste 102, Albemarle, NC 28001 Phone: 704-982-0122 Fax: 704-982-0125 | |
Terica Natasha Young, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 923 N 2nd St, Ste 105, Albemarle, NC 28001 Phone: 704-403-1877 | |
David Brent Joye, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1000 N 1st St Ste 1, Albemarle, NC 28001 Phone: 704-983-2117 Fax: 704-983-2636 |